Ignite Creation Date:
2025-12-24 @ 2:31 PM
Ignite Modification Date:
2026-01-26 @ 12:16 PM
Study NCT ID:
NCT01401959
Status:
COMPLETED
Last Update Posted:
2018-06-15
First Post:
2011-07-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Trial of Eribulin in Patients Who Do Not Achieve Pathologic Complete Response (pCR) Following Neoadjuvant Chemotherapy
Sponsor:
SCRI Development Innovations, LLC
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2011-09-23
Start Date Type:
ACTUAL
Primary Completion Date:
2017-04-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-04-03
Completion Date Type:
ACTUAL
First Submit Date:
2011-07-20
First Submit QC Date:
None
Study First Post Date:
2011-07-26
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-04-04
Results First Submit QC Date:
None
Results First Post Date:
2018-05-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2018-05-16
Last Update Post Date:
2018-06-15
Last Update Post Date Type:
ACTUAL